Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H KELLER

Showing results (711-720 of 818) with videos related to

Pageof 82
Sort By:
Journal of Medicinal Chemistry|June 24, 2010
Spirotetrahydro beta-carbolines (spiroindolones): a new class of potent and orally efficacious compounds for the treatment of malariaBryan K S Yeung, Bin Zou, Matthias Rottmann, et al.
Sozial- Und Praventivmedizin|January 1, 1997
SAPALDIA: methods and participation in the cross-sectional part of the Swiss Study on Air Pollution and Lung Diseases in AdultsB W Martin, U Ackermann-Liebrich, P Leuenberger, et al.
American Journal of Respiratory and Critical Care Medicine|January 1, 1997
Lung function and long term exposure to air pollutants in Switzerland. Study on Air Pollution and Lung Diseases in Adults (SAPALDIA) TeamU Ackermann-Liebrich, P Leuenberger, J Schwartz, et al.
The Journal of Experimental Medicine|October 7, 2021
Targeting EYA2 tyrosine phosphatase activity in glioblastoma stem cells induces mitotic catastropheGuoxin Zhang, Zhen Dong, Ryan C Gimple, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2008
Peptide deformylase inhibitors of Mycobacterium tuberculosis: synthesis, structural investigations, and biological resultsArkadius Pichota, Jeyaraj Duraiswamy, Zheng Yin, et al.
Journal of Medicinal Chemistry|March 25, 2016
Structure-Activity Relationship Studies of Mitogen Activated Protein Kinase Interacting Kinase (MNK) 1 and 2 and BCR-ABL1 Inhibitors Targeting Chronic Myeloid Leukemic CellsJoseph Cherian, Kassoum Nacro, Zhi Ying Poh, et al.
Journal of Medicinal Chemistry|January 8, 2020
Stepwise Evolution of Fragment Hits against MAPK Interacting Kinases 1 and 2Jacek Kwiatkowski, Boping Liu, Shermaine Pang, et al.
Science (New York, N.Y.)|September 4, 2010
Spiroindolones, a potent compound class for the treatment of malariaMatthias Rottmann, Case McNamara, Bryan K S Yeung, et al.
Bioorganic & Medicinal Chemistry Letters|March 6, 2007
Potent and selective xanthine-based inhibitors of phosphodiesterase 5Nichola J Arnold, Ruth Arnold, David Beer, et al.
Bioorganic & Medicinal Chemistry|September 8, 2004
Synthesis and biological properties of novel glucocorticoid androstene C-17 furoate estersDavid A Sandham, Lucy Barker, David Beattie, et al.
Pageof 82

Showing results (711-720 of 818) with videos related to

Sort By:
Pageof 82
Journal of Medicinal Chemistry|June 24, 2010
Spirotetrahydro beta-carbolines (spiroindolones): a new class of potent and orally efficacious compounds for the treatment of malariaBryan K S Yeung, Bin Zou, Matthias Rottmann, et al.
Sozial- Und Praventivmedizin|January 1, 1997
SAPALDIA: methods and participation in the cross-sectional part of the Swiss Study on Air Pollution and Lung Diseases in AdultsB W Martin, U Ackermann-Liebrich, P Leuenberger, et al.
American Journal of Respiratory and Critical Care Medicine|January 1, 1997
Lung function and long term exposure to air pollutants in Switzerland. Study on Air Pollution and Lung Diseases in Adults (SAPALDIA) TeamU Ackermann-Liebrich, P Leuenberger, J Schwartz, et al.
The Journal of Experimental Medicine|October 7, 2021
Targeting EYA2 tyrosine phosphatase activity in glioblastoma stem cells induces mitotic catastropheGuoxin Zhang, Zhen Dong, Ryan C Gimple, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2008
Peptide deformylase inhibitors of Mycobacterium tuberculosis: synthesis, structural investigations, and biological resultsArkadius Pichota, Jeyaraj Duraiswamy, Zheng Yin, et al.
Journal of Medicinal Chemistry|March 25, 2016
Structure-Activity Relationship Studies of Mitogen Activated Protein Kinase Interacting Kinase (MNK) 1 and 2 and BCR-ABL1 Inhibitors Targeting Chronic Myeloid Leukemic CellsJoseph Cherian, Kassoum Nacro, Zhi Ying Poh, et al.
Journal of Medicinal Chemistry|January 8, 2020
Stepwise Evolution of Fragment Hits against MAPK Interacting Kinases 1 and 2Jacek Kwiatkowski, Boping Liu, Shermaine Pang, et al.
Science (New York, N.Y.)|September 4, 2010
Spiroindolones, a potent compound class for the treatment of malariaMatthias Rottmann, Case McNamara, Bryan K S Yeung, et al.
Bioorganic & Medicinal Chemistry Letters|March 6, 2007
Potent and selective xanthine-based inhibitors of phosphodiesterase 5Nichola J Arnold, Ruth Arnold, David Beer, et al.
Bioorganic & Medicinal Chemistry|September 8, 2004
Synthesis and biological properties of novel glucocorticoid androstene C-17 furoate estersDavid A Sandham, Lucy Barker, David Beattie, et al.
Pageof 82